Anti-GAD65 RIA Kit [CE]

GAD65 autoantibodiesare present in 70-80 % of newly diagnosed patients withtype 1 diabetesand can be detected many years before clinical onset of the disease. The combination of the autoantibodies to GAD65 and IA2 is highly relevant for risk assessment of type 1 diabetes in children and adolescence. These tests in combination are more sensitive and predictive than ICA in risk groups, e.g. relatives of type 1 diabetes. GAD65 autoantibodies also occur in a subset of adults with type 2 diabetes (no